Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

103.800
-3.700-3.44%
Volume:17.01M
Turnover:1.76B
Market Cap:181.03B
PE:189.24
High:106.400
Open:104.300
Low:101.500
Close:107.500
52wk High:112.700
52wk Low:69.550
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:0.95
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.549
ROE:7.01%
ROA:2.10%
PB:7.48
PE(LYR):189.24
PS:9.88

Loading ...

Innovent doses first patient in Phase 3 China trial of IBI3003 tri-specific antibody for multiple myeloma

Reuters
·
Jun 22

Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of Ibi3003(Gprc5d/Bcma/Cd3 Tri-Specific Antibody) for the Treatment of Multiple Myeloma

THOMSON REUTERS
·
Jun 22

Innovent Biologics (SEHK:1801) Stock Could Be 49% Below Fair Value After ADA Pipeline Update

Simply Wall St.
·
Jun 22

Movement Alert|Innovent Biologics Rises 3.07% in Regular Trading, Biotech Sector Rally and EULAR Conference Data Provide Dual Catalysts

Market Focus
·
Jun 18

Novo Nordisk to seek approval soon to sell Wegovy pill in China

Reuters
·
Jun 16

INNOVENT BIO Grants 5,000 Share Options and 105,200 Restricted Shares

Stock News
·
Jun 15

Innovent grants 105,200 restricted shares under 2024 share plan

Reuters
·
Jun 15

Movement Alert|Innovent Biologics Rises 3.01% in Regular Trading, First Domestic PCSK9 Inhibitor Approval and ADA Data Catalyze Rebound

Market Focus
·
Jun 15

Innovent Biologics (SEHK:1801) Stock Valuation After Key Obesity Data And Priority Review Cancer Milestone

Simply Wall St.
·
Jun 14

Movement Alert|Innovent Biologics Rises 3.22% in Regular Trading, Technical Rebound After Multi-Day Decline as Biotech Sector Recovers

Market Focus
·
Jun 12

How Investors May Respond To Innovent Biologics (SEHK:1801) Advancing Oral And Extended-Interval GLP-1 Candidates

Simply Wall St.
·
Jun 11

Movement Alert|Innovent Biologics Falls 3.03% in Regular Trading, Pfizer Partnership Regulatory Uncertainty and Sector-Wide Selling Pressure Weigh on Stock

Market Focus
·
Jun 11

BREAKINGVIEWS-Pentagon casts dark cloud over China biotech

Reuters
·
Jun 09

Movement Alert|Innovent Biologics Falls 3.07% in Regular Trading, Pfizer Partnership Regulatory Uncertainty and Biotech Sector Selling Pressure Weigh on Shares

Market Focus
·
Jun 09

2026 Ada | Innovent Presents Multiple Clinical and Preclinical Results of Next-Generation Obesity & Metabolic Pipeline

THOMSON REUTERS
·
Jun 08

Innovative Drug Stocks Under Broad Selling Pressure as Liquidity Tightening Weighs on Valuations; Analysts View BINSA Bill Impact as Sentiment-Driven

Stock News
·
Jun 08

Domestic Innovative Drugs Initiate Paradigm Shift in First-Line NSCLC Treatment, Says Orient Securities

Stock News
·
Jun 08

Movement Alert|Innovent Biologics Falls 3.59% in Regular Trading, Pfizer Deal Regulatory Approval Uncertainty Continues to Weigh on Stock

Market Focus
·
Jun 08

BUZZ-Innovent climbs most in a week on new drug application for gastric cancer

Reuters
·
Jun 05

Movement Alert|Innovent Biologics Rises 3.01% in Regular Trading, Global First CLDN18.2 ADC Drug Application Accepted for Gastric Cancer

Market Focus
·
Jun 05